CVS Health Return on Tangible Equity 2012-2026 | CVS
Current and historical return on tangible equity values for CVS Health (CVS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| CVS Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2026-06-30 | $4.89B | $-34.27B | -14.27% |
| 2026-03-31 | $2.93B | $-36.69B | -7.99% |
| 2025-12-31 | $1.77B | $-38.62B | -4.58% |
| 2025-09-30 | $0.47B | $-40.44B | -1.16% |
| 2025-06-30 | $4.53B | $-41.85B | -10.83% |
| 2025-03-31 | $5.28B | $-43.00B | -12.28% |
| 2024-12-31 | $4.61B | $-44.30B | -10.41% |
| 2024-09-30 | $5.02B | $-44.55B | -11.26% |
| 2024-06-30 | $7.19B | $-45.15B | -15.92% |
| 2024-03-31 | $7.32B | $-46.13B | -15.87% |
| 2023-12-31 | $8.34B | $-44.37B | -18.81% |
| 2023-09-30 | $8.63B | $-41.20B | -20.95% |
| 2023-06-30 | $2.97B | $-37.66B | -7.87% |
| 2023-03-31 | $4.09B | $-33.36B | -12.27% |
| 2022-12-31 | $4.31B | $-32.02B | -13.46% |
| 2022-09-30 | $3.37B | $-32.41B | -10.41% |
| 2022-06-30 | $8.38B | $-32.87B | -25.49% |
| 2022-03-31 | $8.13B | $-34.09B | -23.86% |
| 2021-12-31 | $8.00B | $-35.48B | -22.55% |
| 2021-09-30 | $7.58B | $-37.53B | -20.19% |
| 2021-06-30 | $7.20B | $-39.56B | -18.21% |
| 2021-03-31 | $7.40B | $-41.53B | -17.81% |
| 2020-12-31 | $7.18B | $-43.58B | -16.47% |
| 2020-09-30 | $7.95B | $-45.51B | -17.48% |
| 2020-06-30 | $8.26B | $-47.54B | -17.37% |
| 2020-03-31 | $7.22B | $-49.57B | -14.57% |
| 2019-12-31 | $6.63B | $-51.31B | -12.93% |
| 2019-09-30 | $4.47B | $-53.30B | -8.38% |
| 2019-06-30 | $4.33B | $-43.42B | -9.97% |
| 2019-03-31 | $-0.17B | $-33.39B | 0.51% |
| 2018-12-31 | $-0.59B | $-23.04B | 2.58% |
| 2018-09-30 | $3.11B | $-12.48B | -24.94% |
| 2018-06-30 | $3.01B | $-13.94B | -21.58% |
| 2018-03-31 | $6.67B | $-15.29B | -43.62% |
| 2017-12-31 | $6.62B | $-16.54B | -40.05% |
| 2017-09-30 | $5.04B | $-16.67B | -30.25% |
| 2017-06-30 | $5.30B | $-16.48B | -32.15% |
| 2017-03-31 | $5.12B | $-16.41B | -31.22% |
| 2016-12-31 | $5.32B | $-15.91B | -33.41% |
| 2016-09-30 | $5.11B | $-15.88B | -32.17% |
| 2016-06-30 | $4.81B | $-15.28B | -31.50% |
| 2016-03-31 | $5.16B | $-11.19B | -46.14% |
| 2015-12-31 | $5.24B | $-7.45B | -70.30% |
| 2015-09-30 | $5.06B | $-3.74B | -135.19% |
| 2015-06-30 | $4.76B | $-0.35B | -1352.84% |
| 2015-03-31 | $4.74B | $-0.16B | -2978.62% |
| 2014-12-31 | $4.64B | $0.09B | 5495.86% |
| 2014-09-30 | $4.59B | $0.54B | 850.42% |
| 2014-06-30 | $4.89B | $1.11B | 439.36% |
| 2014-03-31 | $4.77B | $1.76B | 270.62% |
| 2013-12-31 | $4.59B | $2.21B | 207.43% |
| 2013-09-30 | $4.44B | $2.12B | 209.25% |
| 2013-06-30 | $4.20B | $1.70B | 247.46% |
| 2013-03-31 | $4.04B | $1.42B | 284.10% |
| 2012-12-31 | $3.86B | $1.41B | 275.12% |
| 2012-09-30 | $3.81B | $1.46B | 261.30% |
| 2012-06-30 | $3.68B | $1.55B | 237.94% |
| 2012-03-31 | $3.53B | $1.53B | 230.92% |
| 2011-12-31 | $3.46B | $1.71B | 202.34% |
| 2011-09-30 | $3.42B | $1.84B | 185.86% |
| 2011-06-30 | $3.36B | $1.86B | 181.32% |
| 2011-03-31 | $3.37B | $1.54B | 219.23% |
| 2010-12-31 | $3.43B | $0.89B | 384.09% |
| 2010-09-30 | $3.45B | $0.32B | 1076.23% |
| 2010-06-30 | $3.66B | $0.01B | 34083.72% |
| 2010-03-31 | $3.73B | $0.04B | 9150.92% |
| 2009-12-31 | $3.70B | $-0.10B | -3820.16% |
| 2009-09-30 | $3.59B | $-0.43B | -838.74% |
| 2009-06-30 | $3.31B | $-0.49B | -678.85% |
| 2009-03-31 | $3.19B | $-0.88B | -364.06% |
| 2008-12-31 | $3.20B | $-1.26B | -253.11% |
| 2008-09-30 | $3.06B | $-1.68B | -182.20% |
| 2008-06-30 | $3.01B | $-2.07B | -145.91% |
| 2008-03-31 | $2.96B | $-2.48B | -119.70% |
| 2007-12-31 | $2.62B | $-1.40B | -187.62% |
| 2007-09-30 | $2.23B | $0.71B | 312.94% |
| 2007-06-30 | $1.82B | $2.40B | 75.88% |
| 2007-03-31 | $1.43B | $4.24B | 33.82% |
| 2006-12-31 | $1.36B | $5.23B | 25.91% |
| 2006-09-30 | $1.34B | $5.31B | 25.29% |
| 2006-06-30 | $1.31B | $5.45B | 24.09% |
| 2006-03-31 | $1.25B | $5.57B | 22.44% |
| 2005-12-31 | $1.21B | $5.19B | 23.31% |
| 2005-09-30 | $1.06B | $4.81B | 22.01% |
| 2005-06-30 | $0.99B | $4.47B | 22.19% |
| 2005-03-31 | $0.95B | $4.52B | 21.02% |
| 2004-12-31 | $0.91B | $4.61B | 19.65% |
| 2004-09-30 | $0.91B | $4.73B | 19.29% |
| 2004-06-30 | $0.92B | $4.86B | 18.85% |
| 2004-03-31 | $0.88B | $4.63B | 19.04% |
| 2003-12-31 | $0.83B | $4.41B | 18.89% |
| 2003-09-30 | $0.77B | $4.22B | 18.23% |
| 2003-06-30 | $0.75B | $4.06B | 18.39% |
| 2003-03-31 | $0.72B | $3.90B | 18.52% |
| 2002-12-31 | $0.70B | $3.76B | 18.67% |
| 2002-09-30 | $0.37B | $3.61B | 10.30% |
| 2002-06-30 | $0.33B | $3.62B | 9.14% |
| 2002-03-31 | $0.35B | $3.66B | 9.61% |
| 2001-12-31 | $0.40B | $3.70B | 10.77% |
| 2001-09-30 | $0.74B | $3.72B | 19.93% |
| 2001-06-30 | $0.78B | $3.58B | 21.72% |
| 2001-03-31 | $0.77B | $3.41B | 22.48% |
| 2000-12-31 | $0.74B | $3.24B | 22.71% |
| 2000-09-30 | $0.71B | $3.11B | 22.87% |
| 2000-06-30 | $0.68B | $3.00B | 22.65% |
| 2000-03-31 | $0.66B | $2.88B | 22.90% |
| 1999-12-31 | $0.64B | $2.77B | 22.98% |
| 1999-09-30 | $0.60B | $2.62B | 22.74% |
| 1999-06-30 | $0.58B | $2.46B | 23.46% |
| 1999-03-31 | $0.43B | $2.29B | 18.74% |
| 1998-12-31 | $0.40B | $2.06B | 19.19% |
| 1998-09-30 | $0.36B | $1.85B | 19.49% |
| 1998-06-30 | $0.34B | $1.67B | 20.44% |
| 1998-03-31 | $0.10B | $1.49B | 6.99% |
| 1997-12-31 | $0.06B | $1.37B | 4.68% |
| 1997-09-30 | $0.04B | $1.26B | 3.40% |
| 1997-06-30 | $0.04B | $1.26B | 3.26% |
| 1997-03-31 | $0.22B | $1.26B | 17.69% |
| 1996-12-31 | $0.15B | $1.31B | 11.10% |
| 1996-09-30 | $-0.56B | $1.36B | -40.69% |
| 1996-06-30 | $-0.64B | $1.47B | -43.52% |
| 1996-03-31 | $-0.57B | $1.60B | -35.66% |
| 1995-12-31 | $-0.66B | $1.72B | -38.24% |
| 1995-09-30 | $0.17B | $1.86B | 8.97% |
| 1995-06-30 | $0.22B | $1.85B | 12.09% |
| 1995-03-31 | $0.24B | $1.85B | 12.89% |
| 1994-12-31 | $0.31B | $1.86B | 16.58% |
| 1994-09-30 | $0.33B | $1.83B | 18.19% |
| 1994-06-30 | $0.32B | $1.81B | 17.80% |
| 1994-03-31 | $0.35B | $1.77B | 19.84% |
| 1993-12-31 | $0.33B | $1.73B | 19.24% |
| 1993-09-30 | $0.13B | $1.71B | 7.71% |
| 1993-06-30 | $0.15B | $1.72B | 8.45% |
| 1993-03-31 | $0.15B | $1.72B | 8.57% |
| 1992-12-31 | $0.16B | $1.72B | 9.16% |
| 1992-09-30 | $0.35B | $1.71B | 20.68% |
| 1992-06-30 | $0.36B | $1.67B | 21.33% |
| 1992-03-31 | $0.34B | $1.62B | 20.88% |
| 1991-12-31 | $0.35B | $1.57B | 22.11% |
| 1991-09-30 | $0.35B | $1.53B | 22.88% |
| 1991-06-30 | $0.36B | $1.49B | 23.90% |
| 1991-03-31 | $0.38B | $1.47B | 25.58% |
| 1990-12-31 | $0.39B | $1.43B | 26.87% |
| 1990-09-30 | $0.39B | $1.38B | 28.17% |
| 1990-06-30 | $0.40B | $1.36B | 29.26% |
| 1990-03-31 | $0.38B | $1.38B | 27.61% |
| 1989-12-31 | $0.40B | $1.41B | 28.15% |
| 1989-09-30 | $0.37B | $1.46B | 25.03% |
| 1989-06-30 | $0.36B | $1.49B | 23.96% |
| 1989-03-31 | $0.36B | $1.47B | 24.13% |
| 1988-12-31 | $0.35B | $1.45B | 24.40% |
| 1988-09-30 | $0.31B | $1.42B | 21.78% |
| 1988-06-30 | $0.30B | $1.37B | 21.63% |
| 1988-03-31 | $0.30B | $1.32B | 22.77% |
| 1987-12-31 | $0.29B | $1.27B | 22.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $122.206B | $402.067B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |